LifeSemantics, a digital health platform provider, said Monday that it would release the confirmatory clinical trial results of its home blood pressure prediction software (SW) in March.

LifeSemantics initiated the confirmatory clinical trial on July 6 of last year and concluded the final patient enrollment in December. The clinical trial is conducted at Chonnam National University Hospital, Bucheon St. Mary's Hospital, and Hanyang University Hospital. Currently, clinical data collection for validation of the software has been completed.

LifeSemantics' home blood pressure prediction SW is medical artificial intelligence (AI) software that helps patients with hypertension develop a treatment and management plan. Patients record their blood pressure through a mobile app at home for eight weeks, and the software predicts their next blood pressure one to four weeks later based on clinical data.

"As the prevalence of hypertension increases, along with the duration of the disease, regular home blood pressure measurements are becoming increasingly important," said Hong Seung-yong, head of the Medical Devices Division at LifeSemantics.

Hong added that the home blood pressure prediction software would be meaningful in collaboration with blood pressure monitor companies to support efficient blood pressure management, noting that the company is contacting leading international sphygmomanometer manufacturers to supply its algorithms and tap into a market of over 3.5 trillion won ($2.6 billion) globally.